Thermo Fisher Scientific to Acquire Life Technologies Corporation
Thermo Fisher and Life Technologies, a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year-end 2012).
The transaction combines two industry leaders to create the unrivaled leader in research, specialty diagnostics and applied markets. The combination builds on both companies' technological strengths to accelerate results for life sciences customers working in proteomics, genomics and cell biology.
Source: Life Technologies Corp.